在妇科瘤学中使用免疫检查点抑制剂:现状和前景
Nozomu Yanaihara1, Ka Yu Tse2, Sung Jong Lee3
1Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.
概括
免疫检查点抑制剂 (ICI) 在治疗宫癌和子宫内膜癌等妇科癌症,特别是具有特定生物标志物的治疗中具有前景. 组合疗法和生物标志物研究是改善患者结果的关键.
科学领域:
- 妇科瘤学
- 免疫疗法
- 癌症治疗
背景情况:
- 通过利用免疫系统, 免疫检查点抑制剂 (ICI) 正在彻底改变癌症治疗.
- 妇科癌症,包括子宫,子宫内膜和卵巢癌,越来越多地成为ICI的目标.
研究的目的:
- 审查ICI在妇科瘤学中的当前应用和未来方向.
- 突出ICI在特定妇科瘤类型中的有效性,并确定挑战.
主要方法:
- 对宫,子宫内膜,卵巢和罕见妇科癌症的ICI研究的综合文献综述.
- 基于瘤突变负担,PD- L1表达和微卫星不稳定性的疗效分析.
主要成果:
- 在宫癌和不匹配修复缺陷的子宫内膜癌中显示有效性.
- 由于免疫性较低,对微卫星稳定的子宫内膜癌和卵巢癌存在挑战.
- 组合疗法 (例如抗血管生成药物,PARP抑制剂,化疗) 是有前途的.
结论:
- 激进治疗正在改变妇科癌症的治疗方法,
- 进一步研究组合疗法和生物标志物对于优化ICI疗效至关重要.
- 管理与免疫相关的不良事件对于成功实施ICI至关重要.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.0K
09:04Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
661
相关概念视频
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
